Joint Formulary & PAD

Antazoline with xylometazoline - Allergic conjunctivitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Eye drops
Associated Icons :
Restrictions / Comments :
Important

Antazoline with Xylometazoline (Otrivine-Antistin) eye drops have been DISCONTINUED (Oct 2025)

Sodium cromoglycate 2% eye drops or Olopatadine eye drops may be a suitable alternative.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Antazoline with xylometazoline
Indication :
Allergic conjunctivitis
Group Name :
Keywords :
Hay fever, hayfever, xylometazoline and antazoline
Brand Names Include :
Otrivine-antistin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (2)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Otrivine-Antistin (Xylometazoline and antazoline sulfate) is suitable for rapid, short-term relief of infrequent ocular symptoms - avoid in angle-closure glaucoma

Available to buy over the counter (OTC). 

Other Indications

Below are listed other indications that Antazoline with xylometazoline is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Allergic conjunctivitis.